Skip to main content

Drug Delivery Summit 2019, Las Vegas, USA

About Conference

On behalf of PULSUS Conferences, we announce “3rd World Drug Delivery and Formulations Summit” which will be held from April 15-16, 2019 at Las Vegas, USA The conference will be organized around the theme “Endorse the endeavour for modern therapeutic era in Drug Delivery System’’. Drug Delivery Summit 2019 is mainly focuses on future research in drug delivery systems and pharmaceutical formulations.
The Conference provides the research work of pharmaceutics, drug delivery and formulations expertise from various scientific backgrounds and the same can be perceived by pharmaceutical scientists and students. Drug delivery Summit 2019 brings unique platform for scientists, researchers, academicians, biomedical engineers, professors and students to share their knowledge and views also presenting research about trends and advances in drug delivery and formulations. PULSUS provides an opportunistic environment and vibrant podium through these auspicious events to amplify these steps and meet the highest demand ever, by reflexive and cerebrative connections.

Target audience

  • Scientists
  • Researchers from Pharmaceutical companies
  • Biomedical engineers
  • Pharmaceutical associations and societies
  • Professors & Associate professors
  • Medical universities
  • Pharmacists
  • Students
  • Research Associates
  • Directors/Managers/CEO’s
  • Presidents & Vice-presidents

Why to attend?
Drug Delivery Summit 2019 will educate the public with recent advances in Pharmaceutics, drug delivery and formulations around the world and to sharpen the related ideas about Drug Delivery Systems. Moreover, Drug Delivery Summit 2019 provides you a great networking with peer network. Also, Drug Delivery Summit 2019 includes, 10+ Keynote Speaker Session, 50+ speaker faculty over 2 full days sharing Evidence Based, 5+ Workshops, 13 Interactive sessions, Mixture of Health care units and Academia Delegates, Networking provide a dedicated forum for the advancement, execution, and exchange of information about Pharmaceutics, drug delivery and formulations.
PULSUS which organizes 1000+ Global events every year is delighted to welcome all the enthusiastic participants across the world to its prestigious Drug Delivery Conference named “3rd World Drug Delivery and Formulations Summit” which is going to be held during April 15-16, 2019 at Las Vegas, USA.
PULSUS has been progressively organizing scientific conferences across the globe, rendezvous which consist of various streams of scientific study to improve and accelerate discovery for a better tomorrow. The non-profit firm plans for organizing an average of 1000 international conferences per year which is supported by 700 open access journals and 80,000 Editorial Board Members. The number of reader views of the website has clocked 7.5 million and still counting. Lately, around more than 1000 scientific associations of various fields from all over the world have shown interest in association with PULSUS to promote their research work. PULSUS conferences offer exciting features like international symposia, B2B meetings, trade shows, exhibitions, and international workshops to build global networking and meaningful academic research and industry alliances. PULSUS initiated the 'Young Scientist Awards' to the enterprising young science researchers and scholars across the globe.
Drug Delivery Summit 2019 provides an excellent opportunity to share views, exchange knowledge and establish research collaborations & networking.

Scientific Sessions

Session 1: Novel drug delivery systems
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Session 2: Respiratory drug delivery systems
Respiratory infections represent a major global health problem. They are often treated by parenteral administrations of antimicrobials. Unfortunately, systemic therapies of high-dose antimicrobials can lead to severe adverse effects and this calls for a need to develop inhaled formulations that enable targeted drug delivery to the airways with minimal systemic drug exposure. Recent technological advances facilitate the development of inhaled anti-microbial therapies. Novel particle engineering and intelligent device design also make dry powder inhalers appealing for the delivery of high-dose antibiotics.
Session 3: Effect of Pharmacotherapy on drug delivery systems
Pharmacotherapy can be characterized as the treatment and counteractive action of ailment and ailment by methods for medications of the synthetic or organic root. It positions among essential techniques for therapeutic treatment, together with surgery, physical therapy, radiation, and psychotherapy. Although it is practically difficult to appraise the correct degree of the effect of pharmacotherapy on human well-being, there can be almost certain that pharmacotherapy, together with enhanced sanitation, better-eating regimen, and better lodging, has improved individuals. Phenomenal advancements in genomics and atomic science today offer a plenty of new medication targets. The utilization of present-day concoction manufactured strategies empowers the blend of many medication hopefuls in shorter circumstances than at any other time.
Session 4: Skin associated drug delivery
For more than two decades, researchers have attempted to find a way to use the skin as a portal of entry for drugs to overcome problems associated with traditional modes of drug administration. This has been a complicated task due to the highly effective barrier properties of the skin. To deliver drugs through the skin, most compounds require various degrees of permeation enhancement. More recent research makes use of innovative vesicular carriers, electrically assisted delivery and various micro invasive methods, some incorporating technologies from other fields. These new and exciting methods for drug delivery are already increasing the number and quality of dermal and transdermal therapies.
Session 5: Nanoparticles for drug delivery
The use of nanotechnology in medicine and more specifically drug delivery is set to spread rapidly. Currently many substances are under investigation for drug delivery and more specifically for cancer therapy. Interestingly pharmaceutical sciences are using nanoparticles to reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the patient. Recent years have witnessed unprecedented growth of research and applications in nanoscience and nanotechnology. Anticipated applications in medicine include drug delivery, both in vitro and in vivo diagnostics, nutraceuticals and production of improved biocompatible materials.
Session 6: Liposomal and targeted drug delivery
Liposomes, which are biodegradable and essentially non-toxic vehicles, can encapsulate both hydrophilic and hydrophobic materials, and are utilized as drug carriers in drug delivery systems. In addition, liposomes can be used to carry radioactive compounds as radiotracers can be linked to multiple locations in liposomes. In the past two decades there have been major advances in the development of liposomal drug delivery systems suitable for applications ranging from cancer chemotherapy to gene therapy.
Session 7:Transporters in drug discovery and delivery
Drug transporters are now increasingly recognized as important determinants of variable drug disposition and response. In addition, transporter associated problems appear to be occurring with greater frequency during the drug discovery and development process. Drug transporters are expressed in many tissues such as the intestine, liver, kidney, and brain, and play key roles in drug absorption, distribution, and excretion. The information on the functional characteristics of drug transporters provides important information to allow improvements in drug delivery or drug design by targeting specific transporter proteins.
Session 8: Drug targeting and design
Many drug targets are localized to particular subcellular compartments. Yet current drug design strategies are focused on bioavailability and tissue targeting and rarely address drug delivery to specific intracellularcompartments. Insights into how the cell traffics its constituents to these different cellular locations could improve drug design. The process of the design/discovery of drugs typically involves understanding the character of targets (e.g. enzyme, cell, tissues, etc) related to the disease, setting-up the concept of drug design, providing lead compounds (via traditional medicines, natural products, biological macromolecules, compound libraries, computational chemistry, etc.), and design and lead optimization by means of analyzing structure-activity-relationships. A deep understanding of this process in addition to the mode of action at a molecular level will help pharmacists with decisions on appropriate dosing and administration of medicines.
Session 9: Vaccine drug delivery systems
Vaccines are the preparations given to patients to evoke immune responses leading to the production of antibodies (humoral) or cell-mediated responses that will combat infectious agents or noninfectious conditions such as malignancies. Vaccine is a material that induces an immunologically mediated resistance to a disease but not necessarily an infection. Vaccines are generally composed of killed or attenuated organisms or subunits of organisms or DNA encoding antigenic proteins of pathogens. However, the selectivity and specificity of sub-units of the causative organism like proteins, carbohydrates can be exploited for producing strong and prolonged immune responses by catering them to the immune system in such a way that a specific and strong immuneresponse is induced.
Session 10: Preformulation and formulation aspects
Preformulation is a group of studies that focus on the physicochemical properties of a new drug candidate that could affect the drug performance and the development of a dosage form. This could provide important information for formulation design or support the need for molecular modification. Every drug has intrinsic chemical and physical properties which has been consider before development of pharmaceutical formulation. This property provides the framework for drugs combination with pharmaceutical ingredients in the fabrication of dosage form. Objective of preformulation study is to develop the elegant, stable, effective and safe dosage form by establishing kinetic rate profile, compatibility with the other ingredients and establish physico-chemical parameter of new drug substances.
Session 11: Anti-cancer drug delivery agents
In the past, our limited understanding of the processes involved in the initiation and growth of cancer hindered our ability to effectively treat most human malignancies and therapies were often associated with significant toxic side effects as well as re-emergence of disease. For years, chemotherapy has been a mainstay treatment option for inoperable cancers. The development of drug delivery systems such as liposomes has improved the specificity of various conventional anticancer agents by enhancing drug accumulation in tumours while often decreasing exposure to susceptible healthy tissues. More recently, the identification of a wide range of genes and corresponding protein products that are altered in various human cancers has revealed new molecular targets for cancer therapy that may provide improved selectivity for tumour cells over traditional cytotoxic agents.
Session 12: Injectable drug delivery
The increasing use of biologics, a rise in the prevalence of chronic diseases, increasing occurrence of needlestick injuries, and the benefits of injections (convenience, ease of use, and reduced pain) are increasing the demand for safety syringes, prefilled syringes (PFS), and autoinjectors. Across the globe, the injectable route of drug administration is the most widely applied method of drug delivery after oral drug administration method. Growth in injectable drug delivery technologies market is likely to be hinged at China, India, Brazil, and Mexico in the coming years as the U.S. and European market reaches maturation. Growing incidence of cancer, and diabetes, rapid urbanization, improving healthcare infrastructure, and rising need for better technologies are pivotal factors driving the injectable drug delivery technologies market in these regions.
Session 13: Biopharmaceutical formulations
Biopharmaceutical products are molecules that are the components of biological systems that are used in the treatment of human and animal health and disease. Formulation development of biopharmaceutical protein therapeutics. Production of biopharmaceutical involves many different, complex and lengthy steps which synthesis are, purification, formulation, final dosage preparation. Applications of biopharmaceuticals are agonist and antagonist of important receptors and enzymes, vaccines. The combination of biological molecules like antibodies with cytoxic compounds and agents, such as antibody drug used in cancer therapies.
Session 14: Herbal drug formulations
Herbal formulation defines as a mean dosage form consisting of one or more herbs in specified quantities to provide specific nutritional, cosmetic benefits and used to treat, diagnose, mitigate diseases of human beings. Herbal drugs/herbal formulations are finished labelled products that contain active ingredients such as aerial or underground parts of plant or combinations whether in the crude state or as plant preparations. Herbal preparations are available in different forms including fresh, dried, in tablets, or capsules, or bottled in liquid form. Very rare pharmaceutical companies are involved in drug discovery screening from natural sources.
Session 15: Developments in drug delivery
Drug delivery is playing an increasingly significant role in the quest for new product opportunities as the pharmaceutical industry faces patent and pipeline challenges. Also, growing healthcare costs are shifting in-patient treatments to the home setting. As a result, injection delivery methods are on the rise, particularly for the treatment of chronic conditions. Improved methods for the development, manufacture, and administration of drugs, particularly increasingly complex biologics such as protein and peptide therapeutics, are more in demand than ever and are being met with advanced drug delivery options.
Session 16: Formulations and routes of administration
Drugs can be given to a person in a variety of formulations. Formulations is a mixture in a particular state that the drug is supplied to the patient. It can be either solid, semisolid or liquid formulations. The type of formulation given to a patient depends upon the type of patient and the condition of the patient (such as age, sex, and health condition). Also, the type of formulation is specific for particular routes of administration.
Session 17: Peptides and protein drug delivery
While the peptide and protein therapeutic market has developed significantly in the past decades, delivery has limited their use. Although oral delivery is preferred, most are currently delivered intravenously or subcutaneously due to degradation and limited absorption in the gastrointestinal tract. Due to rapid progress in biotechnology, as well as gene technology, the industry can produce many potential therapeutic peptides and proteins in commercial quantities. Endogenous proteins and peptides play an important role in the regulation and integration of life processes and act with high specificity and potency. Peptides and proteins have great potential as therapeutics. Currently, the market for peptide and protein drugs is estimated to be greater than US$40 billion/year, or 10% of the pharmaceutical market. This market is growing much faster than that of small molecules and will make up an even larger proportion of the market in the future.
Session 18:Future research in DDS
In the last few decades, advances in nanomedicinebiotechnology, chemistry and materials science have re-ignited scientific and industrial interest in drug delivery research in an exponential manner. Innovation is drug delivery is an important part in product lifecycle management as well as for product differentiation in new drug development. Facing greater challenges in bringing new molecular entities to market, the large pharma companies are seeking to capitalize on advances in drug delivery for a competitive advantage.
Session 19: Biomaterials and polymers used in DD
Biomaterials are widely used in numerous medical applications. Chemical engineering has played a central role in this research and development. Polymers as biomaterials, materials and approaches used in drug and proteindelivery systems, materials used as scaffolds in tissue engineering, and nanotechnology and microfabrication techniques applied to biomaterials. Drug delivery systems have unusual materials requirements which derive mainly from their therapeutic role: to administer drugs over prolonged periods of time at rates that are independent of patient-to-patient variables. Selection of materials for such systems is further complicated by the need for compatibility with the drug contained within the system.
Session 20: DDS used in current medical practice
Numerous new medications have been developed to effectively treat complicated conditions, but at the same time some of them produce severe side effects that the benefit does not always outweigh the risk. Some drugs have been proven to be very effective in vitro but cannot withstand the endogenous enzymes found within the gastrointestinal (GI) tract (if taken orally), deeming them nearly worthless in vivo. While incredible progress has been made in identifying drug targets, designing and making better drug molecules; there is still room to improve the drug delivery systems and targeting

Submit your abstract here: